What’s the problem? [Bioanalytics]

posted by auditor – India, 2012-02-16 13:23 (4859 d 14:50 ago) – Posting: # 8129
Views: 7,041

❝ In European Pharmacopea and / or USP is a statement that it is allowed to maximum deviate 5% from the stated weight in the monographs.


I do agree with you. but here the topic is what to do if some thing is prepared high then the establish one.

I just want to say we need to inject one P&A to justify slightly increased ULOQ. Here we are not changing the range but using of ULOQ which is just slightly beyond the establish one in method validation.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
35 visitors (0 registered, 35 guests [including 14 identified bots]).
Forum time: 05:14 CEST (Europe/Vienna)

There is no point in being precise when you don’t know
what you’re talking about.    attributed to John Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5